Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combining Solid and Liquid Biopsy for Therapy Monitoring in Esophageal Cancer.

International journal of molecular sciences - 26 Jun 2023

Richter Florian, Henssen Clara, Steiert Tim Alexander, Meissner Tobias, Mehdorn Anne-Sophie, Röcken Christoph, Franke Andre, Egberts Jan-Hendrik, Becker Thomas, Sebens Susanne, Forster Michael

Abstract excerpt

Esophageal cancer (EC) has one of the highest mortality rates among cancers, making it imperative that therapies are optimized and dynamically adapted to individuals. In this regard, liquid biopsy is an increasingly important method for residual disease monitoring. However, conflicting detection rates (14% versus 60%) and varying cell-free circulating tumor DNA (ctDNA) levels (0.07% versus 0.5%) have been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Esophageal Neoplasms

Share to Homeodomain Proteins

Share to Liquid Biopsy

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 37445849
DOI: 10.3390/ijms241310673
PMCID: PMC10341643

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combining Solid and Liquid Biopsy for Therapy Monitoring in Esophageal Cancer.PMID 37445849Read ↗

A Review of Circulating Tumor DNA in the Diagnosis and Monitoring of Esophageal Cancer.Semantic proximity Read ↗

Liquid Biopsy for Investigation of Cancer DNA in Esophageal Squamous Cell Carcinoma.Semantic proximity Read ↗

ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality.Semantic proximity Read ↗

Liquid Biopsy for Investigation of Cancer DNA in Esophageal Adenocarcinoma: Cell-Free Plasma DNA and Exosome-Associated DNA.Semantic proximity Read ↗

Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in PlasmaSemantic proximity Read ↗

Circulating Tumor DNA in Gastric and Gastroesophageal Junction CancerSemantic proximity Read ↗

Molecular landscape of esophageal cancer: implications for early detection and personalized therapy.Semantic proximity Read ↗

Noninvasive diagnosis and monitoring of mutations by deep sequencing of circulating tumor DNA in esophageal squamous cell carcinoma.Semantic proximity Read ↗

Frequent tumor burden monitoring of esophageal squamous cell carcinoma with circulating tumor DNA using individually designed digital PCRSemantic proximity Read ↗

Liquid Biopsy in Gastric Cancer: Analysis of Somatic Cancer Tissue Mutations in Plasma Cell-Free DNA for Predicting Disease State and Patient Survival.Semantic proximity Read ↗

Liquid Biopsy-Based Accurate Diagnosis and Genomic Profiling of Hard-to-Biopsy Tumors via Parallel Single-Cell Genomic Sequencing of Exfoliated Tumor Cells.Semantic proximity Read ↗

Genome-wide and panel-based cell-free DNA characterization of patients with resectable esophageal adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.